Read up on the latest
news from BioReperia
Explore our latest news articles on how our contract research organization accelerates pre-clinical drug development.

FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative

BioReperia represented at Tumor Models Nordics
Pros and cons of the ZTX model

New article published

Zebrafish predict treatment in lungcancer

Join BioReperias FREE webinars

The 50 “companies-for-the-future” this year – BioReperia is one of the finalists in Techarenan Challenge 2021!

Job opening

BioReperia presents at PREDiCT: Tumor models London

New R&D project

On-demand webinar
